drsairahahmed
@drsairahahmed
Followers
106
Following
191
Statuses
87
Assoc Professor, Depts of Lymphoma/Myeloma and SCT/Cellular Therapy ~Director CAR-T Lymphoma/Myeloma Program ~ UTMDACC~ tweets = own views
Houston, Texas
Joined September 2024
RT @NashvilleHeme: The NHC Debate Club at #NashvilleHeme25 is ready to bring the heat! Get ready for an "after-school" style showdown where…
0
8
0
RT @WomenInLymphoma: 💜 With a huge amount of gratitude, pride & sadness, it is now time to say goodbye as the EA of @WomeninLymphoma since…
0
2
0
RT @JoshuaRichterMD: Wonderful collaboration between @MonicaWattana and her group @MDAndersonNews and @TischCancer . A primer for em…
0
6
0
RT @WomenInLymphoma: 🟣 Are you on the @WomenInLymphoma mailing list? Join to receive educational webinar details, quarterly newsletter, in-…
0
5
0
🌟 Join us for @lymphoma LRF virtual grand rounds tonight moderated by myself, @KrishPatelMD and @ARosenthalDO 🌟 ✔️ register now ✔️ @MayoCancerCare
@SarahCannonDocs @MDAndersonNews
0
3
4
RT @JoshuaRichterMD: Congrats to @RahulBanerjeeMD @VincentRK @szusmani @Myeloma_Doc @myelomaMD et al for this extremely clinicall…
0
29
0
RT @lymphomahub: 📝 Results from a recent study, STARGLO, published in @TheLancet found that glofitamab plus gemcitabine-oxaliplatin was wel…
0
7
0
RT @CIBMTR: A CIBMTR study looked at a CAR-T called axicabtagene ciloleucel, or axi-cel. In the study, 1,300 people got axi-cel during 2017…
0
3
0
RT @MuhammadJTariq: Congratulations a lot @FaizAnwerMD1 You have inspired and mentored so many students and trainees to achieve their goals…
0
4
0
RT @Lymphoma_Doc: Congrats to @EMittendorfMD, @SoniSmithMD, @n8pennell, Dr. Dillmon, @ErikaHamilton9, @DrRanaMcKay, and @SuzanneColeMD! I'm…
0
8
0
Fantastic presentation at the #MDAservicelineretreat by the LM team @Lymphoma_Doc Misha Hawkins, Krista Moore, Amira Pugh @MDAndersonNews
0
1
4
RT @DrCCutler: As #ASH24 comes to an end, I bring you the annual door drop waste photo. @ASH_hematology, stop this immense waste!!!! https:…
0
12
0
RT @Lymphoma_Doc: Wow: Tafasitamab significantly improved outcomes when combined with R-Len in patients with relapsed follicular lymphoma.…
0
36
0
RT @laura_korin: @WomenInLymphoma breakfast at #ASH24. Truly inspiring meeting and so happy to be a part of WiL!
0
8
0
RT @graham74GC: Neelapu: long term Zuma5 FU (Axi-cel FL) - 127 efficacy pts, R/R FL 2+ prior lines - at >5y FU, >50% alive, no further Rx -…
0
9
0
RT @DrKrinaPatel: Fantastic job by #OrenPasvolsky presenting RWE for the safe and effective use of teclistamab for older RRMM patients (one…
0
11
0
RT @ACPIMPhysicians: Happy #InternalMedicineDay from ACP President Omar T. Atiq, M.D., MACP! Explore our I.M. Physician Toolkit for resou…
0
23
0
RT @DrJFriedberg: Now in print @JCO_ASCO: Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratificati…
0
9
0
RT @MDAndersonNews: Our Dr. Sanam Loghavi is in booth 1949 at #ASH24 to share more about hematopathology at MD Anderson. @sanamloghavi #E…
0
12
0